Vertebral morphometry in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate treatment

Bone

Volumn 39, Issue 4, 2006, Pages 901-906

  Land, Christof ^a,b   Rauch, Frank ^a,b   Munns, Craig F ^a,b   Sahebjam, Solmaz ^a,b   Glorieux, Francis H ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bisphosphonates; Children; Metabolic bone disease; Osteogenesis imperfecta; Osteoporosis

Indexed keywords

PAMIDRONIC ACID;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BONE DENSITY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; MULTIPLE REGRESSION; OSTEOGENESIS IMPERFECTA; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TREATMENT RESPONSE; VERTEBRA BODY; VERTEBRA MALFORMATION; X RAY;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; CHILD; CHILD, PRESCHOOL; DENSITOMETRY, X-RAY; DIPHOSPHONATES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; OSTEOGENESIS IMPERFECTA; REGRESSION ANALYSIS; SPINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748186513     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.04.004     Document Type: Article

References (20)

1. Rauch F., and Glorieux F.H. Osteogenesis imperfecta. Lancet 363 (2004) 1377-1385
2. Kok D.J., Uiterwaal C.S., Van Dongen A.J., Kramer P.P., Pruijs H.E., Engelbert R.H., et al. The interaction between Sillence type and BMD in osteogenesis imperfecta. Calcif Tissue Int 73 (2003) 441-445
3. Ishikawa S., Kumar S.J., Takahashi H.E., and Homma M. Vertebral body shape as a predictor of spinal deformity in osteogenesis imperfecta. J Bone Jt Surg Am 78 (1996) 212-219
4. Engelbert R.H., Gerver W.J., Breslau-Siderius L.J., van der Graaf Y., Pruijs H.E., van Doorne J.M., et al. Spinal complications in osteogenesis imperfecta: 47 patients 1-16 years of age. Acta Orthop Scand 69 (1998) 283-286
5. McAllion S.J., and Paterson C.R. Causes of death in osteogenesis imperfecta. J Clin Pathol 49 (1996) 627-630
6. Glorieux F.H., Bishop N.J., Plotkin H., Chabot G., Lanoue G., and Travers R. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339 (1998) 947-952
7. Astrom E., and Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86 (2002) 356-364
8. Zacharin M., and Bateman J. Pamidronate treatment of osteogenesis imperfecta-lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response. J Pediatr Endocrinol Metab 15 (2002) 163-174
9. Arikoski P., Silverwood B., Tillmann V., and Bishop N.J. Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy. Bone 34 (2004) 539-546
10. Rauch F., Plotkin H., Zeitlin L., and Glorieux F.H. Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy. J Bone Miner Res 18 (2003) 610-614
11. Munns C.F., Rauch F., Travers R., and Glorieux F.H. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 20 (2005) 1235-1243
12. Ferrar L., Jiang G., Adams J., and Eastell R. Identification of vertebral fractures: an update. Osteoporos Int 16 (2005) 717-728
13. Sumnik Z., Land C., Rieger-Wettengl G., Korber F., Stabrey A., and Schoenau E. Effect of pamidronate treatment on vertebral deformity in children with primary osteoporosis. A pilot study using radiographic morphometry. Horm Res 61 (2004) 137-142
14. Letocha A.D., Cintas H.L., Troendle J.F., Reynolds J.C., Cann C.E., Chernoff E.J., et al. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. J Bone Miner Res 20 (2005) 977-986
15. Ogden C.L., Kuczmarski R.J., Flegal K.M., Mei Z., Guo S., Wei R., et al. Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109 (2002) 45-60
16. Bollen A.M., and Eyre D.R. Bone resorption rates in children monitored by the urinary assay of collagen type I cross-linked peptides. Bone 15 (1994) 31-34
17. Smith-Bindman R., Cummings S.R., Steiger P., and Genant H.K. A comparison of morphometric definitions of vertebral fracture. J Bone Miner Res 6 (1991) 25-34
18. Eastell R., Cedel S.L., Wahner H.W., Riggs B.L., and Melton III L.J. Classification of vertebral fractures. J Bone Miner Res 6 (1991) 207-215
19. Salle B.L., Braillon P., Glorieux F.H., Brunet J., Cavero E., and Meunier P.J. Lumbar bone mineral content measured by dual energy X-ray absorptiometry in newborns and infants. Acta Paediatr 81 (1992) 953-958
20. Kok D.J., Uiterwaal C.S., Van Dongen A.J., Kramer P.P., Pruijs H.E., Engelbert R.H., et al. The interaction between Sillence type and BMD in osteogenesis imperfecta. Calcif Tissue Int 73 (2003) 441-445